epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Rexulti

brexpiprazole

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Black Box Warnings .

Dementia-Related Psychosis

not approved for dementia-related psychosis without agitation associated with dementia due to Alzheimer disease; incr. mortality risk in elderly patients on antipsychotic tx for dementia-related psychosis; most deaths due to cardiovascular or infectious events

Suicidality

incr. suicidality risk in peds and young adult patients in short-term studies; observe all antidepressant-treated patients for clinical worsening, suicidality, or unusual behavior changes; advise families and caregivers of need for close observation and communication with prescriber; not approved for depression in peds patients

Adult Dosing .

Dosage forms:  TAB: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

major depressive disorder, adjunct tx

[2 mg PO qd]
Start: 0.5-1 mg PO qd, may incr. dose qwk; Max: 3 mg/day; Info: decr. dose 50% in CYP2D6 poor metabolizers; periodically reassess need for tx

schizophrenia

[2-4 mg PO qd]
Start: 1 mg PO qd x4 days, then 2 mg PO qd x3 days, then may incr. to 4 mg PO qd; Max: 4 mg/day; Info: decr. dose 50% in CYP2D6 poor metabolizers; periodically reassess need for tx

dementia-associated agitation, patients with Alzheimer disease

[2 mg PO qd]
Start: 0.5 mg PO qd x7 days, then 1 mg PO qd x7 days, then 2 mg PO qd, then may incr. to 3 mg PO qd after at least 14 days; Max: 3 mg/day; Info: decr. dose 50% in CYP2D6 poor metabolizers; periodically reassess need for tx

renal dosing

[schizophrenia]
CrCl <60: max 3 mg/day
HD/PD: not defined
[all other indications]
CrCl <60: max 2 mg/day
HD/PD: not defined

hepatic dosing

[schizophrenia]
Child-Pugh Class B or C: max 3 mg/day
[all other indications]
Child-Pugh Class B or C: max 2 mg/day

Peds Dosing .

Dosage forms:  TAB: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg

schizophrenia

[13-17 yo]
Dose: 2-4 mg PO qd; Start: 0.5 mg PO qd x4 days, then 1 mg PO qd x3 days, then may incr. to 2 mg PO qd, then may incr. by 1 mg/day qwk; Max: 4 mg/day; Info: decr. dose 50% in CYP2D6 poor metabolizers; periodically reassess need for tx

renal dosing

[adjust dose amount]
CrCl <60: max 3 mg/day
HD/PD: not defined

hepatic dosing

[adjust dose amount]
Child-Pugh Class B or C: max 3 mg/day

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@571ba32c
  • hypersensitivity to drug or ingredient
  • caution: cardiovascular disease
  • caution: MI history
  • caution: ischemic heart disease
  • caution: heart failure
  • caution: hypovolemia
  • caution: dehydration
  • caution: hypotension, orthostatic
  • caution: hepatic impairment, moderate-severe
  • caution: CrCl <60
  • caution: aspiration pneumonia risk
  • caution: elderly patients
  • caution: cerebrovascular disease
  • caution: psychosis, dementia-associated
  • caution: seizure history
  • caution: seizure threshold, lowered
  • caution: CYP2D6 poor metabolizers
  • caution: diabetes mellitus
  • caution: diabetes mellitus risk
  • caution: environmental temperature, high
  • caution: patients <25 yo (depression use)
  • caution: leukopenia history, drug-induced
  • caution: neutropenia history, drug-induced
  • caution: leukopenia
  • caution: neutropenia

Drug Interactions .

Overview

brexpiprazole

atypical antipsychotic

Interaction Characteristics:
  • CYP2D6 substrate
  • CYP3A4 substrate
  • CNS depression
  • decreases central histamine effects
  • extrapyramidal effects
  • hyperglycemic effects
  • hyperthermia
  • hypotensive effects
  • lowers seizure threshold

Avoid/Use Alternative

  • aldesleukin
  • Rexulti (brexpiprazole)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + aldesleukin

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, severe or life-threatening hypotension (including orthostasis, syncope), seizures (additive effects)

  • amifampridine
  • Rexulti (brexpiprazole)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • aripiprazole bimonthly injection
  • Rexulti (brexpiprazole)
    +
    aripiprazole bimonthly injection
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + aripiprazole bimonthly injection

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole lauroxil
  • Rexulti (brexpiprazole)
    +
    aripiprazole lauroxil
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + aripiprazole lauroxil

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole monthly injection
  • Rexulti (brexpiprazole)
    +
    aripiprazole monthly injection
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + aripiprazole monthly injection

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • aripiprazole oral
  • Rexulti (brexpiprazole)
    +
    aripiprazole oral
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + aripiprazole oral

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • asenapine
  • Rexulti (brexpiprazole)
    +
    asenapine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + asenapine

    use alternative or monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • benztropine
  • Rexulti (brexpiprazole)
    +
    benztropine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + benztropine

    consider alternative: combo may incr. risk of hyperthermia, hyperthermia, including life-threatening (additive effects)

  • butalbital
  • Rexulti (brexpiprazole)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + butalbital

    avoid combo: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • clonidine
  • Rexulti (brexpiprazole)
    +
    clonidine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + clonidine

    if ADHD use, avoid combo; otherwise, monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • codeine
  • Rexulti (brexpiprazole)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + codeine

    avoid combo if antitussive use; otherwise monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • doxylamine
  • Rexulti (brexpiprazole)
    +
    doxylamine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + doxylamine

    avoid combo if doxylamine use for pregnancy-related nausea/vomiting, otherwise caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ethanol (alcoholic beverage)
  • Rexulti (brexpiprazole)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + ethanol (alcoholic beverage)

    avoid combo: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ethanol injection
  • Rexulti (brexpiprazole)
    +
    ethanol injection
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + ethanol injection

    use alternative or monitor respiratory rate, BP: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • grapefruit
  • Rexulti (brexpiprazole)
    +
    grapefruit
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + grapefruit

    avoid grapefruit juice: combo may incr. brexpiprazole levels, risk of adverse effects (GI metabolism inhibited)

  • haloperidol
  • Rexulti (brexpiprazole)
    +
    haloperidol
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + haloperidol

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hypotension, including orthostasis, syncope (additive effects)

  • hydrocodone
  • Rexulti (brexpiprazole)
    +
    hydrocodone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + hydrocodone

    avoid combo if antitussive use; otherwise monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • iloperidone
  • Rexulti (brexpiprazole)
    +
    iloperidone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + iloperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • isocarboxazid
  • Rexulti (brexpiprazole)
    +
    isocarboxazid
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + isocarboxazid

    use alternative during and x10 days after isocarboxazid use; monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • kava
  • Rexulti (brexpiprazole)
    +
    kava
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + kava

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • kratom
  • Rexulti (brexpiprazole)
    +
    kratom
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + kratom

    use alternative or monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • lofexidine
  • Rexulti (brexpiprazole)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + lofexidine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • lumateperone
  • Rexulti (brexpiprazole)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + lumateperone

    use alternative or monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • lurasidone
  • Rexulti (brexpiprazole)
    +
    lurasidone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + lurasidone

    use alternative or monitor BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • metaxalone
  • Rexulti (brexpiprazole)
    +
    metaxalone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + metaxalone

    use alternative or monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • metoclopramide
  • Rexulti (brexpiprazole)
    +
    metoclopramide
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + metoclopramide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • midazolam
  • Rexulti (brexpiprazole)
    +
    midazolam
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + midazolam

    use alternative or monitor respiratory rate, BP; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • milsaperidone
  • Rexulti (brexpiprazole)
    +
    milsaperidone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + milsaperidone

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • netupitant
  • Rexulti (brexpiprazole)
    +
    netupitant
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + netupitant

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, use alternative or decr. brexpiprazole dose 75% during and x1wk after (fos)netupitant tx: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • olanzapine
  • Rexulti (brexpiprazole)
    +
    olanzapine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + olanzapine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • oxybate
  • Rexulti (brexpiprazole)
    +
    oxybate
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + oxybate

    use alternative or monitor respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, syncope (additive effects)

  • phenelzine
  • Rexulti (brexpiprazole)
    +
    phenelzine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + phenelzine

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • pitolisant
  • Rexulti (brexpiprazole)
    +
    pitolisant
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + pitolisant

    avoid combo: combo may decr. pitolisant efficacy (antagonistic effects)

  • promethazine
  • Rexulti (brexpiprazole)
    +
    promethazine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + promethazine

    use alternative or monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension (including orthostasis, syncope), seizures, extrapyramidal symptoms, hyperthermia (additive effects)

  • ropeginterferon alfa-2b
  • Rexulti (brexpiprazole)
    +
    ropeginterferon alfa-2b
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + ropeginterferon alfa-2b

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • scopolamine
  • Rexulti (brexpiprazole)
    +
    scopolamine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + scopolamine

    use alternative: combo may increase risk of CNS depression, psychomotor impairment, hyperthermia, including life-threatening (additive effects)

  • thalidomide
  • Rexulti (brexpiprazole)
    +
    thalidomide
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + thalidomide

    use alternative or monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tradipitant
  • Rexulti (brexpiprazole)
    +
    tradipitant
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + tradipitant

    use alternative: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tranylcypromine
  • Rexulti (brexpiprazole)
    +
    tranylcypromine
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + tranylcypromine

    use alternative or monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • trimethobenzamide
  • Rexulti (brexpiprazole)
    +
    trimethobenzamide
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + trimethobenzamide

    avoid combo: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • ziprasidone
  • Rexulti (brexpiprazole)
    +
    ziprasidone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + ziprasidone

    use alternative or monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, other adverse effects (additive effects, duplicate therapy)

  • zuranolone
  • Rexulti (brexpiprazole)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    brexpiprazole + zuranolone

    use alternative or consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Monitor/Modify Tx

  • abiraterone acetate
  • Rexulti (brexpiprazole)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + abiraterone acetate

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • acarbose
  • Rexulti (brexpiprazole)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • Rexulti (brexpiprazole)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + acebutolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • adagrasib
  • Rexulti (brexpiprazole)
    +
    adagrasib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + adagrasib

    decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • alfentanil
  • Rexulti (brexpiprazole)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + alfentanil

    monitor BP, respiratory rate; decr. dose of one or both drugs: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Rexulti (brexpiprazole)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Rexulti (brexpiprazole)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • alogliptin
  • Rexulti (brexpiprazole)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprazolam
  • Rexulti (brexpiprazole)
    +
    alprazolam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + alprazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • alprostadil intracavernous
  • Rexulti (brexpiprazole)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis, syncope (additive effects)

  • amantadine
  • Rexulti (brexpiprazole)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amantadine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • amifostine
  • Rexulti (brexpiprazole)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amiloride
  • Rexulti (brexpiprazole)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amitriptyline
  • Rexulti (brexpiprazole)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amitriptyline

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • amlodipine
  • Rexulti (brexpiprazole)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amoxapine
  • Rexulti (brexpiprazole)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + amoxapine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • apalutamide
  • Rexulti (brexpiprazole)
    +
    apalutamide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + apalutamide

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • apomorphine
  • Rexulti (brexpiprazole)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + apomorphine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Rexulti (brexpiprazole)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • aprepitant
  • Rexulti (brexpiprazole)
    +
    aprepitant
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + aprepitant

    if aprepitant 3-day regimen, decr. brexpiprazole dose 75% if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor; aprepitant single dose-regimen OK: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • aprocitentan
  • Rexulti (brexpiprazole)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • articaine
  • Rexulti (brexpiprazole)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • atazanavir
  • Rexulti (brexpiprazole)
    +
    atazanavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + atazanavir

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • atenolol
  • Rexulti (brexpiprazole)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • avacopan
  • Rexulti (brexpiprazole)
    +
    avacopan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + avacopan

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • avanafil
  • Rexulti (brexpiprazole)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Rexulti (brexpiprazole)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • baclofen intrathecal
  • Rexulti (brexpiprazole)
    +
    baclofen intrathecal
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + baclofen intrathecal

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • benazepril
  • Rexulti (brexpiprazole)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + benazepril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • berberine
  • Rexulti (brexpiprazole)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + berberine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • berotralstat
  • Rexulti (brexpiprazole)
    +
    berotralstat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + berotralstat

    decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • betaxolol
  • Rexulti (brexpiprazole)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • betaxolol ophthalmic
  • Rexulti (brexpiprazole)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bethanechol
  • Rexulti (brexpiprazole)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bexagliflozin
  • Rexulti (brexpiprazole)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bexagliflozin

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bisoprolol
  • Rexulti (brexpiprazole)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bortezomib
  • Rexulti (brexpiprazole)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bortezomib

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • bosentan
  • Rexulti (brexpiprazole)
    +
    bosentan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bosentan

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • brimonidine ophthalmic
  • Rexulti (brexpiprazole)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • brimonidine topical
  • Rexulti (brexpiprazole)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + brimonidine topical

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • bromocriptine
  • Rexulti (brexpiprazole)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bromocriptine

    monitor BP, glucose in type 2 diabetes mellitus pts: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bumetanide
  • Rexulti (brexpiprazole)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bumetanide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bupivacaine
  • Rexulti (brexpiprazole)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • bupivacaine liposomal
  • Rexulti (brexpiprazole)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • buprenorphine
  • Rexulti (brexpiprazole)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + buprenorphine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • bupropion
  • Rexulti (brexpiprazole)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + bupropion

    consider lower bupropion doses; decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no brexpiprazole adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of seizures, other adverse effects (hepatic metabolism inhibited, additive effects)

  • butorphanol
  • Rexulti (brexpiprazole)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + butorphanol

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Rexulti (brexpiprazole)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • canagliflozin
  • Rexulti (brexpiprazole)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + canagliflozin

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • candesartan cilexetil
  • Rexulti (brexpiprazole)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cannabis
  • Rexulti (brexpiprazole)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cannabis

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • capivasertib
  • Rexulti (brexpiprazole)
    +
    capivasertib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + capivasertib

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • captopril
  • Rexulti (brexpiprazole)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carbamazepine
  • Rexulti (brexpiprazole)
    +
    carbamazepine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + carbamazepine

    monitor BP; double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment, hypotension, including syncope; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • cariprazine
  • Rexulti (brexpiprazole)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cariprazine

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects, duplicate therapy)

  • carteolol ophthalmic
  • Rexulti (brexpiprazole)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • carvedilol
  • Rexulti (brexpiprazole)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + carvedilol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cenobamate
  • Rexulti (brexpiprazole)
    +
    cenobamate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cenobamate

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • ceritinib
  • Rexulti (brexpiprazole)
    +
    ceritinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ceritinib

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • Rexulti (brexpiprazole)
    +
    chloramphenicol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chloramphenicol

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • chlordiazepoxide
  • Rexulti (brexpiprazole)
    +
    chlordiazepoxide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chlordiazepoxide

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • chloroprocaine
  • Rexulti (brexpiprazole)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorothiazide
  • Rexulti (brexpiprazole)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorpromazine
  • Rexulti (brexpiprazole)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chlorpromazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • chlorthalidone
  • Rexulti (brexpiprazole)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + chlorthalidone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cilostazol
  • Rexulti (brexpiprazole)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cinacalcet
  • Rexulti (brexpiprazole)
    +
    cinacalcet
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cinacalcet

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ciprofloxacin
  • Rexulti (brexpiprazole)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ciprofloxacin

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clarithromycin
  • Rexulti (brexpiprazole)
    +
    clarithromycin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clarithromycin

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clevidipine
  • Rexulti (brexpiprazole)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • clobazam
  • Rexulti (brexpiprazole)
    +
    clobazam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clobazam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • clofarabine
  • Rexulti (brexpiprazole)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • clofazimine
  • Rexulti (brexpiprazole)
    +
    clofazimine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clofazimine

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • clomipramine
  • Rexulti (brexpiprazole)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clomipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), seizures, hyperthermia (additive effects)

  • clonazepam
  • Rexulti (brexpiprazole)
    +
    clonazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clonazepam

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • clorazepate
  • Rexulti (brexpiprazole)
    +
    clorazepate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clorazepate

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • clozapine
  • Rexulti (brexpiprazole)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + clozapine

    monitor BP, HR: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, seizures, extrapyramidal symptoms, hyperthermia (additive effects)

  • cobicistat
  • Rexulti (brexpiprazole)
    +
    cobicistat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cobicistat

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • coenzyme Q-10
  • Rexulti (brexpiprazole)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • colesevelam
  • Rexulti (brexpiprazole)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • conivaptan
  • Rexulti (brexpiprazole)
    +
    conivaptan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + conivaptan

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75% during and x7 days after conivaptan tx: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • crizotinib
  • Rexulti (brexpiprazole)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + crizotinib

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • cyclosporine
  • Rexulti (brexpiprazole)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + cyclosporine

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • dabrafenib
  • Rexulti (brexpiprazole)
    +
    dabrafenib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dabrafenib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • dacomitinib
  • Rexulti (brexpiprazole)
    +
    dacomitinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dacomitinib

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • danazol
  • Rexulti (brexpiprazole)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + danazol

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • dapagliflozin
  • Rexulti (brexpiprazole)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dapagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • daridorexant
  • Rexulti (brexpiprazole)
    +
    daridorexant
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + daridorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darunavir
  • Rexulti (brexpiprazole)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + darunavir

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • denileukin diftitox
  • Rexulti (brexpiprazole)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • desflurane
  • Rexulti (brexpiprazole)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + desflurane

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • desipramine
  • Rexulti (brexpiprazole)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + desipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • dexmedetomidine
  • Rexulti (brexpiprazole)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dexmedetomidine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Rexulti (brexpiprazole)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dexmedetomidine injection

    monitor BP, respiratory rate, consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • diazepam
  • Rexulti (brexpiprazole)
    +
    diazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + diazepam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • dihydrocodeine
  • Rexulti (brexpiprazole)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dihydrocodeine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Rexulti (brexpiprazole)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + diltiazem

    monitor BP; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of hypotension (including orthostasis, syncope), other adverse effects (hepatic metabolism inhibited, additive effects)

  • dinutuximab
  • Rexulti (brexpiprazole)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • dipyridamole
  • Rexulti (brexpiprazole)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • doxazosin
  • Rexulti (brexpiprazole)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Rexulti (brexpiprazole)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + doxepin

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dronabinol
  • Rexulti (brexpiprazole)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dronabinol

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • dronedarone
  • Rexulti (brexpiprazole)
    +
    dronedarone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dronedarone

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • droperidol
  • Rexulti (brexpiprazole)
    +
    droperidol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + droperidol

    decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dulaglutide
  • Rexulti (brexpiprazole)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Rexulti (brexpiprazole)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + duloxetine

    monitor BP; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), other adverse effects (hepatic metabolism inhibited, additive effects)

  • duvelisib
  • Rexulti (brexpiprazole)
    +
    duvelisib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + duvelisib

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • efavirenz
  • Rexulti (brexpiprazole)
    +
    efavirenz
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + efavirenz

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • eliglustat
  • Rexulti (brexpiprazole)
    +
    eliglustat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + eliglustat

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • empagliflozin
  • Rexulti (brexpiprazole)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + empagliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • enalapril
  • Rexulti (brexpiprazole)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • enalaprilat
  • Rexulti (brexpiprazole)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • encorafenib
  • Rexulti (brexpiprazole)
    +
    encorafenib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + encorafenib

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • entacapone
  • Rexulti (brexpiprazole)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + entacapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Rexulti (brexpiprazole)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + entrectinib

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • enzalutamide
  • Rexulti (brexpiprazole)
    +
    enzalutamide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + enzalutamide

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • eplerenone
  • Rexulti (brexpiprazole)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • epoprostenol
  • Rexulti (brexpiprazole)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • ertugliflozin
  • Rexulti (brexpiprazole)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ertugliflozin

    monitor glucose, BP: combo may decr. antidiabetic agent efficacy; may incr. risk of hypotension, including orthostasis, syncope (antagonistic effects; additive effects)

  • erythromycin
  • Rexulti (brexpiprazole)
    +
    erythromycin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + erythromycin

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • esketamine
  • Rexulti (brexpiprazole)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + esketamine

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • esmolol
  • Rexulti (brexpiprazole)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • estazolam
  • Rexulti (brexpiprazole)
    +
    estazolam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + estazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • eszopiclone
  • Rexulti (brexpiprazole)
    +
    eszopiclone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + eszopiclone

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ethacrynic acid
  • Rexulti (brexpiprazole)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ethacrynic acid

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ethanol (in some formulations)
  • Rexulti (brexpiprazole)
    +
    ethanol (in some formulations)
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ethanol (in some formulations)

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etomidate
  • Rexulti (brexpiprazole)
    +
    etomidate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + etomidate

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • etravirine
  • Rexulti (brexpiprazole)
    +
    etravirine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + etravirine

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • etripamil nasal
  • Rexulti (brexpiprazole)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • exenatide
  • Rexulti (brexpiprazole)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fedratinib
  • Rexulti (brexpiprazole)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fedratinib

    decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • felodipine
  • Rexulti (brexpiprazole)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fenoldopam
  • Rexulti (brexpiprazole)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fentanyl
  • Rexulti (brexpiprazole)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fentanyl

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • ferumoxytol
  • Rexulti (brexpiprazole)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fexinidazole
  • Rexulti (brexpiprazole)
    +
    fexinidazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fexinidazole

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • flaxseed
  • Rexulti (brexpiprazole)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + flaxseed

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • flibanserin
  • Rexulti (brexpiprazole)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + flibanserin

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • fluconazole
  • Rexulti (brexpiprazole)
    +
    fluconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fluconazole

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • fluoxetine
  • Rexulti (brexpiprazole)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fluoxetine

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • fluphenazine
  • Rexulti (brexpiprazole)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fluphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • flurazepam
  • Rexulti (brexpiprazole)
    +
    flurazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + flurazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • fosamprenavir
  • Rexulti (brexpiprazole)
    +
    fosamprenavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fosamprenavir

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • fosinopril
  • Rexulti (brexpiprazole)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • foslevodopa
  • Rexulti (brexpiprazole)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + foslevodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • fosphenytoin
  • Rexulti (brexpiprazole)
    +
    fosphenytoin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + fosphenytoin

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • furosemide
  • Rexulti (brexpiprazole)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + furosemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • gabapentin
  • Rexulti (brexpiprazole)
    +
    gabapentin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + gabapentin

    monitor respiratory rate; consider decreasing gabapentin dose: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decrease seizure threshold)

  • gabapentin enacarbil
  • Rexulti (brexpiprazole)
    +
    gabapentin enacarbil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + gabapentin enacarbil

    monitor respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment (additive effects)

  • garlic
  • Rexulti (brexpiprazole)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + garlic

    monitor BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • gilteritinib
  • Rexulti (brexpiprazole)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • givosiran
  • Rexulti (brexpiprazole)
    +
    givosiran
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + givosiran

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited; givosiran effects on hepatic heme biosynthesis may reduce CYP450 enzyme activity)

  • glimepiride
  • Rexulti (brexpiprazole)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • Rexulti (brexpiprazole)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • Rexulti (brexpiprazole)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Rexulti (brexpiprazole)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + guanfacine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • hydralazine
  • Rexulti (brexpiprazole)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • hydrochlorothiazide
  • Rexulti (brexpiprazole)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + hydrochlorothiazide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • hydromorphone
  • Rexulti (brexpiprazole)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + hydromorphone

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxyzine
  • Rexulti (brexpiprazole)
    +
    hydroxyzine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + hydroxyzine

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • idelalisib
  • Rexulti (brexpiprazole)
    +
    idelalisib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + idelalisib

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ifosfamide
  • Rexulti (brexpiprazole)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ifosfamide

    D/C one or both drugs if encephalopathy occurs; otherwise, caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • iloprost
  • Rexulti (brexpiprazole)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • imatinib
  • Rexulti (brexpiprazole)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + imatinib

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • imipramine
  • Rexulti (brexpiprazole)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + imipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • indapamide
  • Rexulti (brexpiprazole)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + indapamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • insulin
  • Rexulti (brexpiprazole)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + insulin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • iohexol
  • Rexulti (brexpiprazole)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + iohexol

    if intrathecal iohexol use, D/C brexpiprazole at least 48h before myelography, may resume at least 24h after procedure: combo may incr. risk of seizures (additive effects)

  • iopamidol
  • Rexulti (brexpiprazole)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + iopamidol

    caution advised if intrathecal iopamidol use; consider holding brexpiprazole at least 48h before and at least 24h after intrathecal iopamidol: combo may incr. risk of seizures (additive effects)

  • irbesartan
  • Rexulti (brexpiprazole)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • iron sucrose
  • Rexulti (brexpiprazole)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • isavuconazonium
  • Rexulti (brexpiprazole)
    +
    isavuconazonium
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + isavuconazonium

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • isoflurane
  • Rexulti (brexpiprazole)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + isoflurane

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • isosorbide dinitrate
  • Rexulti (brexpiprazole)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Rexulti (brexpiprazole)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Rexulti (brexpiprazole)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • itraconazole
  • Rexulti (brexpiprazole)
    +
    itraconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + itraconazole

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ivosidenib
  • Rexulti (brexpiprazole)
    +
    ivosidenib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ivosidenib

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • ketamine
  • Rexulti (brexpiprazole)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ketamine

    monitor respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression (including life-threatening), psychomotor impairment (additive effects)

  • ketoconazole
  • Rexulti (brexpiprazole)
    +
    ketoconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ketoconazole

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • labetalol
  • Rexulti (brexpiprazole)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • landiolol
  • Rexulti (brexpiprazole)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lefamulin
  • Rexulti (brexpiprazole)
    +
    lefamulin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lefamulin

    ORAL LEFAMULIN: if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%; IV lefamulin use OK: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lemborexant
  • Rexulti (brexpiprazole)
    +
    lemborexant
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lemborexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • lenacapavir
  • Rexulti (brexpiprazole)
    +
    lenacapavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lenacapavir

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75% during and x9mo after lenacapavir tx: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • letermovir
  • Rexulti (brexpiprazole)
    +
    letermovir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + letermovir

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • levobunolol ophthalmic
  • Rexulti (brexpiprazole)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levodopa
  • Rexulti (brexpiprazole)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + levodopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • levoketoconazole
  • Rexulti (brexpiprazole)
    +
    levoketoconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + levoketoconazole

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • levorphanol
  • Rexulti (brexpiprazole)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + levorphanol

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • lidocaine
  • Rexulti (brexpiprazole)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • linagliptin
  • Rexulti (brexpiprazole)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • Rexulti (brexpiprazole)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Rexulti (brexpiprazole)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lisinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lithium
  • Rexulti (brexpiprazole)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lithium

    D/C one or both drugs if encephalopathy occurs: combo may incr. risk of encephalopathic syndrome, extrapyramidal symptoms (additive effects)

  • lixisenatide
  • Rexulti (brexpiprazole)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lonafarnib
  • Rexulti (brexpiprazole)
    +
    lonafarnib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lonafarnib

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • lopinavir/ritonavir
  • Rexulti (brexpiprazole)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lopinavir/ ritonavir

    consider brexpiprazole dose adjustment: combo may incr. or decr. brexpiprazole levels, incr. risk of adverse effects or decr. efficacy (hepatic metabolism altered)

  • lorazepam
  • Rexulti (brexpiprazole)
    +
    lorazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lorazepam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • lorlatinib
  • Rexulti (brexpiprazole)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lorlatinib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • losartan
  • Rexulti (brexpiprazole)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • loxapine
  • Rexulti (brexpiprazole)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + loxapine

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • lubiprostone
  • Rexulti (brexpiprazole)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lumacaftor/ivacaftor
  • Rexulti (brexpiprazole)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + lumacaftor/ ivacaftor

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • magnesium sulfate
  • Rexulti (brexpiprazole)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • maraviroc
  • Rexulti (brexpiprazole)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mavacamten
  • Rexulti (brexpiprazole)
    +
    mavacamten
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mavacamten

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • mavorixafor
  • Rexulti (brexpiprazole)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mavorixafor

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • meperidine
  • Rexulti (brexpiprazole)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + meperidine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Rexulti (brexpiprazole)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metformin
  • Rexulti (brexpiprazole)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methadone
  • Rexulti (brexpiprazole)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + methadone

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Rexulti (brexpiprazole)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + methohexital

    monitor respiratory rate, BP: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • methyldopa
  • Rexulti (brexpiprazole)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + methyldopa

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • methylene blue injection
  • Rexulti (brexpiprazole)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metolazone
  • Rexulti (brexpiprazole)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + metolazone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • metoprolol
  • Rexulti (brexpiprazole)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mifepristone
  • Rexulti (brexpiprazole)
    +
    mifepristone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mifepristone

    decr. brexpiprazole dose 50% during and x14 days after daily mifepristone use; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75% during and x14 days after daily mifepristone use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • miglitol
  • Rexulti (brexpiprazole)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milrinone
  • Rexulti (brexpiprazole)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • minoxidil
  • Rexulti (brexpiprazole)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • mirabegron
  • Rexulti (brexpiprazole)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mirabegron

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • mirtazapine
  • Rexulti (brexpiprazole)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mirtazapine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • mitapivat
  • Rexulti (brexpiprazole)
    +
    mitapivat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mitapivat

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • mitotane
  • Rexulti (brexpiprazole)
    +
    mitotane
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + mitotane

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • modafinil
  • Rexulti (brexpiprazole)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + modafinil

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • moexipril
  • Rexulti (brexpiprazole)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • molindone
  • Rexulti (brexpiprazole)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + molindone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia, hypotension, including orthostasis, syncope (additive effects)

  • morphine
  • Rexulti (brexpiprazole)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + morphine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nadolol
  • Rexulti (brexpiprazole)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nadolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nafcillin
  • Rexulti (brexpiprazole)
    +
    nafcillin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nafcillin

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • nalbuphine
  • Rexulti (brexpiprazole)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nalbuphine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Rexulti (brexpiprazole)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nattokinase
  • Rexulti (brexpiprazole)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • naxitamab
  • Rexulti (brexpiprazole)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nebivolol
  • Rexulti (brexpiprazole)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nefazodone
  • Rexulti (brexpiprazole)
    +
    nefazodone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nefazodone

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • nelarabine
  • Rexulti (brexpiprazole)
    +
    nelarabine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nelarabine

    withhold nelarabine if Grade 2 or greater somnolence occurs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • nelfinavir
  • Rexulti (brexpiprazole)
    +
    nelfinavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nelfinavir

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • niacin (vitamin B3)
  • Rexulti (brexpiprazole)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + niacin (vitamin B3)

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nicardipine
  • Rexulti (brexpiprazole)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nifedipine
  • Rexulti (brexpiprazole)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nilotinib
  • Rexulti (brexpiprazole)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nilotinib

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • nimodipine
  • Rexulti (brexpiprazole)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nirogacestat
  • Rexulti (brexpiprazole)
    +
    nirogacestat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nirogacestat

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • nisoldipine
  • Rexulti (brexpiprazole)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nitric oxide
  • Rexulti (brexpiprazole)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • nitrite
  • Rexulti (brexpiprazole)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Rexulti (brexpiprazole)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Rexulti (brexpiprazole)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nortriptyline
  • Rexulti (brexpiprazole)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + nortriptyline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • obinutuzumab
  • Rexulti (brexpiprazole)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • oliceridine
  • Rexulti (brexpiprazole)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + oliceridine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Rexulti (brexpiprazole)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opicapone
  • Rexulti (brexpiprazole)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Rexulti (brexpiprazole)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + opium

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Rexulti (brexpiprazole)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + oxazepam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • oxybutynin
  • Rexulti (brexpiprazole)
    +
    oxybutynin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + oxybutynin

    decr. dose of one or both drugs or consider oxybutynin transdermal patch: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; somnolence less likely with oxybutynin transdermal patch (additive effects)

  • oxycodone
  • Rexulti (brexpiprazole)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + oxycodone

    monitor respiratory rate, BP; decr. oxycodone start dose by at least 50%, consider decr. brexpiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Rexulti (brexpiprazole)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + oxymorphone

    monitor respiratory rate, BP; decr. oxymorphone start dose by at least 50%, consider decr. brexpiprazole dose, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • pacritinib
  • Rexulti (brexpiprazole)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pacritinib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • paliperidone
  • Rexulti (brexpiprazole)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + paliperidone

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • palopegteriparatide
  • Rexulti (brexpiprazole)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • paroxetine
  • Rexulti (brexpiprazole)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + paroxetine

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of CNS depression, psychomotor impairment, other adverse effects (hepatic metabolism inhibited, additive effects)

  • pentamidine
  • Rexulti (brexpiprazole)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pentamidine

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • pentazocine
  • Rexulti (brexpiprazole)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pentazocine

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Rexulti (brexpiprazole)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pentobarbital

    monitor respiratory rate, BP; double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (hepatic metabolism induced; additive effects)

  • perindopril
  • Rexulti (brexpiprazole)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • perphenazine
  • Rexulti (brexpiprazole)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + perphenazine

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of severe hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • pexidartinib
  • Rexulti (brexpiprazole)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pexidartinib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • phenobarbital
  • Rexulti (brexpiprazole)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + phenobarbital

    monitor BP, respiratory rate; double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • phenoxybenzamine
  • Rexulti (brexpiprazole)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • phentolamine
  • Rexulti (brexpiprazole)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • phenytoin
  • Rexulti (brexpiprazole)
    +
    phenytoin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + phenytoin

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • pindolol
  • Rexulti (brexpiprazole)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pindolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pioglitazone
  • Rexulti (brexpiprazole)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • posaconazole
  • Rexulti (brexpiprazole)
    +
    posaconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + posaconazole

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • pramipexole
  • Rexulti (brexpiprazole)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pramipexole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • pramlintide
  • Rexulti (brexpiprazole)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • Rexulti (brexpiprazole)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • pregabalin
  • Rexulti (brexpiprazole)
    +
    pregabalin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + pregabalin

    monitor respiratory rate: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • primidone
  • Rexulti (brexpiprazole)
    +
    primidone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + primidone

    monitor respiratory rate; double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS and respiratory depression, psychomotor impairment; may alter seizure control (hepatic metabolism induced; additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • procarbazine
  • Rexulti (brexpiprazole)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + procarbazine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • prochlorperazine
  • Rexulti (brexpiprazole)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + prochlorperazine

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • propafenone
  • Rexulti (brexpiprazole)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • propofol
  • Rexulti (brexpiprazole)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + propofol

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • propranolol
  • Rexulti (brexpiprazole)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • protriptyline
  • Rexulti (brexpiprazole)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + protriptyline

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • quazepam
  • Rexulti (brexpiprazole)
    +
    quazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + quazepam

    monitor BP, respiratory rate; consider decr. dose of one or both drugs: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • quetiapine
  • Rexulti (brexpiprazole)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + quetiapine

    monitor BP: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • quinapril
  • Rexulti (brexpiprazole)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • quinidine (antiarrhythmic)
  • Rexulti (brexpiprazole)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + quinidine (antiarrhythmic)

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • quinidine (CYP2D6 inhibitor)
  • Rexulti (brexpiprazole)
    +
    quinidine (CYP2D6 inhibitor)
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + quinidine (CYP2D6 inhibitor)

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ramipril
  • Rexulti (brexpiprazole)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rasagiline
  • Rexulti (brexpiprazole)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rasagiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • remifentanil
  • Rexulti (brexpiprazole)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + remifentanil

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Rexulti (brexpiprazole)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + remimazolam

    monitor BP, respiratory rate; use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of hypotension (including orthostasis, syncope), profound CNS and respiratory depression, psychomotor impairment (additive effects)

  • repaglinide
  • Rexulti (brexpiprazole)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • repotrectinib
  • Rexulti (brexpiprazole)
    +
    repotrectinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + repotrectinib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy; may incr. risk of CNS depression, psychomotor impairment (hepatic metabolism induced; additive effects)

  • ribociclib
  • Rexulti (brexpiprazole)
    +
    ribociclib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ribociclib

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • rifabutin
  • Rexulti (brexpiprazole)
    +
    rifabutin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rifabutin

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Rexulti (brexpiprazole)
    +
    rifampin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rifampin

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • rifapentine
  • Rexulti (brexpiprazole)
    +
    rifapentine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rifapentine

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • rilzabrutinib
  • Rexulti (brexpiprazole)
    +
    rilzabrutinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rilzabrutinib

    if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • riociguat
  • Rexulti (brexpiprazole)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • risperidone
  • Rexulti (brexpiprazole)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + risperidone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis, syncope (additive effects)

  • ritonavir
  • Rexulti (brexpiprazole)
    +
    ritonavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ritonavir

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • rolapitant
  • Rexulti (brexpiprazole)
    +
    rolapitant
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rolapitant

    if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • ropinirole
  • Rexulti (brexpiprazole)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ropinirole

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Rexulti (brexpiprazole)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • rosiglitazone
  • Rexulti (brexpiprazole)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • Rexulti (brexpiprazole)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + rotigotine transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • sacubitril
  • Rexulti (brexpiprazole)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • safinamide
  • Rexulti (brexpiprazole)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + safinamide

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • saxagliptin
  • Rexulti (brexpiprazole)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Rexulti (brexpiprazole)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + selegiline

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • selegiline transdermal
  • Rexulti (brexpiprazole)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + selegiline transdermal

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • semaglutide
  • Rexulti (brexpiprazole)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sevoflurane
  • Rexulti (brexpiprazole)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sevoflurane

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • sildenafil
  • Rexulti (brexpiprazole)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • silodosin
  • Rexulti (brexpiprazole)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sitagliptin
  • Rexulti (brexpiprazole)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Rexulti (brexpiprazole)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotagliflozin
  • Rexulti (brexpiprazole)
    +
    sotagliflozin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sotagliflozin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotalol
  • Rexulti (brexpiprazole)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sotalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotorasib
  • Rexulti (brexpiprazole)
    +
    sotorasib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sotorasib

    consider incr. brexpiprazole dose: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • sparsentan
  • Rexulti (brexpiprazole)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Rexulti (brexpiprazole)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + spironolactone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • St. John's wort
  • Rexulti (brexpiprazole)
    +
    St. John's wort
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + St. John's wort

    double brexpiprazole dose over 1-2wk: combo may decr. brexpiprazole levels, efficacy (hepatic metabolism induced)

  • sufentanil
  • Rexulti (brexpiprazole)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + sufentanil

    monitor respiratory rate, BP; decr. sufentanil start dose, consider decr. brexpiprazole dose, use lowest effective doses: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • suvorexant
  • Rexulti (brexpiprazole)
    +
    suvorexant
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + suvorexant

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tadalafil
  • Rexulti (brexpiprazole)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tagraxofusp
  • Rexulti (brexpiprazole)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tamsulosin
  • Rexulti (brexpiprazole)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Rexulti (brexpiprazole)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tapentadol

    monitor respiratory rate, BP; decrease dose of one or both drugs, use lowest effective doses and shortest duration of concomitant treatment: combo may increase risk of profound CNS and respiratory depression, psychomotor impairment, severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Rexulti (brexpiprazole)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • telmisartan
  • Rexulti (brexpiprazole)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + telmisartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • temazepam
  • Rexulti (brexpiprazole)
    +
    temazepam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + temazepam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • terazosin
  • Rexulti (brexpiprazole)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • terbinafine
  • Rexulti (brexpiprazole)
    +
    terbinafine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + terbinafine

    decr. brexpiprazole dose 50%; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; no adjustment if depression adjunct tx use: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • thioridazine
  • Rexulti (brexpiprazole)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + thioridazine

    monitor BP; if also combined w/ moderate or strong CYP3A4 inhibitor, decr. brexpiprazole dose 75%; otherwise, consider decr. dose of one or both drugs: combo may incr. brexpiprazole levels, risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia, other adverse effects (hepatic metabolism inhibited, additive effects)

  • thiothixene
  • Rexulti (brexpiprazole)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + thiothixene

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • timolol
  • Rexulti (brexpiprazole)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + timolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • timolol ophthalmic
  • Rexulti (brexpiprazole)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tipranavir
  • Rexulti (brexpiprazole)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tipranavir

    decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • tirzepatide
  • Rexulti (brexpiprazole)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Rexulti (brexpiprazole)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tizanidine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Rexulti (brexpiprazole)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tolcapone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Rexulti (brexpiprazole)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + torsemide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tramadol
  • Rexulti (brexpiprazole)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tramadol

    monitor respiratory rate, BP; decr. dose of one or both drugs, use lowest effective doses and shortest duration of concomitant tx: combo may incr. risk of profound CNS and respiratory depression, psychomotor impairment, seizures, severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Rexulti (brexpiprazole)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + trandolapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • trazodone
  • Rexulti (brexpiprazole)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + trazodone

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Rexulti (brexpiprazole)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamterene
  • Rexulti (brexpiprazole)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + triamterene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • triazolam
  • Rexulti (brexpiprazole)
    +
    triazolam
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + triazolam

    monitor BP, respiratory rate: combo may incr. risk of CNS and respiratory depression, psychomotor impairment, hypotension, including orthostasis, syncope (additive effects)

  • trifluoperazine
  • Rexulti (brexpiprazole)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension (including orthostasis, syncope), CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • trimipramine
  • Rexulti (brexpiprazole)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + trimipramine

    monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hypotension (including orthostasis, syncope), hyperthermia (additive effects)

  • tucatinib
  • Rexulti (brexpiprazole)
    +
    tucatinib
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + tucatinib

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • valsartan
  • Rexulti (brexpiprazole)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • vardenafil
  • Rexulti (brexpiprazole)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • verapamil
  • Rexulti (brexpiprazole)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + verapamil

    monitor BP; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of hypotension (including orthostasis, syncope), other adverse effects (hepatic metabolism inhibited, additive effects)

  • voriconazole
  • Rexulti (brexpiprazole)
    +
    voriconazole
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + voriconazole

    decr. brexpiprazole dose 50%; if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor, decr. brexpiprazole dose 75%: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

  • vosoritide
  • Rexulti (brexpiprazole)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • yohimbe
  • Rexulti (brexpiprazole)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • zaleplon
  • Rexulti (brexpiprazole)
    +
    zaleplon
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + zaleplon

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • ziconotide
  • Rexulti (brexpiprazole)
    +
    ziconotide
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + ziconotide

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolpidem
  • Rexulti (brexpiprazole)
    +
    zolpidem
    1 interaction

    Monitor/Modify Tx

    brexpiprazole + zolpidem

    consider decr. dose of one or both drugs: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

Caution Advised

  • 5-HTP
  • Rexulti (brexpiprazole)
    +
    5-HTP
    1 interaction

    Caution Advised

    brexpiprazole + 5-HTP

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • acetazolamide
  • Rexulti (brexpiprazole)
    +
    acetazolamide
    1 interaction

    Caution Advised

    brexpiprazole + acetazolamide

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, brexpiprazole may decr. seizure threshold)

  • aclidinium inhaled
  • Rexulti (brexpiprazole)
    +
    aclidinium inhaled
    1 interaction

    Caution Advised

    brexpiprazole + aclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • allopurinol
  • Rexulti (brexpiprazole)
    +
    allopurinol
    1 interaction

    Caution Advised

    brexpiprazole + allopurinol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • almotriptan
  • Rexulti (brexpiprazole)
    +
    almotriptan
    1 interaction

    Caution Advised

    brexpiprazole + almotriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • atropine
  • Rexulti (brexpiprazole)
    +
    atropine
    1 interaction

    Caution Advised

    brexpiprazole + atropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • baclofen
  • Rexulti (brexpiprazole)
    +
    baclofen
    1 interaction

    Caution Advised

    brexpiprazole + baclofen

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • belladonna alkaloids
  • Rexulti (brexpiprazole)
    +
    belladonna alkaloids
    1 interaction

    Caution Advised

    brexpiprazole + belladonna alkaloids

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • botulinum toxin
  • Rexulti (brexpiprazole)
    +
    botulinum toxin
    1 interaction

    Caution Advised

    brexpiprazole + botulinum toxin

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • brivaracetam
  • Rexulti (brexpiprazole)
    +
    brivaracetam
    1 interaction

    Caution Advised

    brexpiprazole + brivaracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • brompheniramine
  • Rexulti (brexpiprazole)
    +
    brompheniramine
    1 interaction

    Caution Advised

    brexpiprazole + brompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • buspirone
  • Rexulti (brexpiprazole)
    +
    buspirone
    1 interaction

    Caution Advised

    brexpiprazole + buspirone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • busulfan
  • Rexulti (brexpiprazole)
    +
    busulfan
    1 interaction

    Caution Advised

    brexpiprazole + busulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • cannabidiol
  • Rexulti (brexpiprazole)
    +
    cannabidiol
    1 interaction

    Caution Advised

    brexpiprazole + cannabidiol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • carbinoxamine
  • Rexulti (brexpiprazole)
    +
    carbinoxamine
    1 interaction

    Caution Advised

    brexpiprazole + carbinoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • carisoprodol
  • Rexulti (brexpiprazole)
    +
    carisoprodol
    1 interaction

    Caution Advised

    brexpiprazole + carisoprodol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • cetirizine
  • Rexulti (brexpiprazole)
    +
    cetirizine
    1 interaction

    Caution Advised

    brexpiprazole + cetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chamomile, German
  • Rexulti (brexpiprazole)
    +
    chamomile, German
    1 interaction

    Caution Advised

    brexpiprazole + chamomile, German

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • chlophedianol
  • Rexulti (brexpiprazole)
    +
    chlophedianol
    1 interaction

    Caution Advised

    brexpiprazole + chlophedianol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorambucil
  • Rexulti (brexpiprazole)
    +
    chlorambucil
    1 interaction

    Caution Advised

    brexpiprazole + chlorambucil

    caution advised: combo may incr. risk of seizures (additive effects)

  • chlorcyclizine
  • Rexulti (brexpiprazole)
    +
    chlorcyclizine
    1 interaction

    Caution Advised

    brexpiprazole + chlorcyclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chloroquine
  • Rexulti (brexpiprazole)
    +
    chloroquine
    1 interaction

    Caution Advised

    brexpiprazole + chloroquine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • chlorpheniramine
  • Rexulti (brexpiprazole)
    +
    chlorpheniramine
    1 interaction

    Caution Advised

    brexpiprazole + chlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • chlorzoxazone
  • Rexulti (brexpiprazole)
    +
    chlorzoxazone
    1 interaction

    Caution Advised

    brexpiprazole + chlorzoxazone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • citalopram
  • Rexulti (brexpiprazole)
    +
    citalopram
    1 interaction

    Caution Advised

    brexpiprazole + citalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • clemastine
  • Rexulti (brexpiprazole)
    +
    clemastine
    1 interaction

    Caution Advised

    brexpiprazole + clemastine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • clidinium
  • Rexulti (brexpiprazole)
    +
    clidinium
    1 interaction

    Caution Advised

    brexpiprazole + clidinium

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • cyclobenzaprine
  • Rexulti (brexpiprazole)
    +
    cyclobenzaprine
    1 interaction

    Caution Advised

    brexpiprazole + cyclobenzaprine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • cyproheptadine
  • Rexulti (brexpiprazole)
    +
    cyproheptadine
    1 interaction

    Caution Advised

    brexpiprazole + cyproheptadine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dantrolene
  • Rexulti (brexpiprazole)
    +
    dantrolene
    1 interaction

    Caution Advised

    brexpiprazole + dantrolene

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • darifenacin
  • Rexulti (brexpiprazole)
    +
    darifenacin
    1 interaction

    Caution Advised

    brexpiprazole + darifenacin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • desvenlafaxine
  • Rexulti (brexpiprazole)
    +
    desvenlafaxine
    1 interaction

    Caution Advised

    brexpiprazole + desvenlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • deutetrabenazine
  • Rexulti (brexpiprazole)
    +
    deutetrabenazine
    1 interaction

    Caution Advised

    brexpiprazole + deutetrabenazine

    caution advised: combo may incr. risk of neuroleptic malignant syndrome, CNS depression, psychomotor impairment (additive effects)

  • dexbrompheniramine
  • Rexulti (brexpiprazole)
    +
    dexbrompheniramine
    1 interaction

    Caution Advised

    brexpiprazole + dexbrompheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dexchlorpheniramine
  • Rexulti (brexpiprazole)
    +
    dexchlorpheniramine
    1 interaction

    Caution Advised

    brexpiprazole + dexchlorpheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • dichlorphenamide
  • Rexulti (brexpiprazole)
    +
    dichlorphenamide
    1 interaction

    Caution Advised

    brexpiprazole + dichlorphenamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dicyclomine
  • Rexulti (brexpiprazole)
    +
    dicyclomine
    1 interaction

    Caution Advised

    brexpiprazole + dicyclomine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • difelikefalin
  • Rexulti (brexpiprazole)
    +
    difelikefalin
    1 interaction

    Caution Advised

    brexpiprazole + difelikefalin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • difenoxin
  • Rexulti (brexpiprazole)
    +
    difenoxin
    1 interaction

    Caution Advised

    brexpiprazole + difenoxin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • dimenhydrinate
  • Rexulti (brexpiprazole)
    +
    dimenhydrinate
    1 interaction

    Caution Advised

    brexpiprazole + dimenhydrinate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenhydramine
  • Rexulti (brexpiprazole)
    +
    diphenhydramine
    1 interaction

    Caution Advised

    brexpiprazole + diphenhydramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • diphenoxylate
  • Rexulti (brexpiprazole)
    +
    diphenoxylate
    1 interaction

    Caution Advised

    brexpiprazole + diphenoxylate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • disopyramide
  • Rexulti (brexpiprazole)
    +
    disopyramide
    1 interaction

    Caution Advised

    brexpiprazole + disopyramide

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • domperidone
  • Rexulti (brexpiprazole)
    +
    domperidone
    1 interaction

    Caution Advised

    brexpiprazole + domperidone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • doxepin topical
  • Rexulti (brexpiprazole)
    +
    doxepin topical
    1 interaction

    Caution Advised

    brexpiprazole + doxepin topical

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • eletriptan
  • Rexulti (brexpiprazole)
    +
    eletriptan
    1 interaction

    Caution Advised

    brexpiprazole + eletriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • elinzanetant
  • Rexulti (brexpiprazole)
    +
    elinzanetant
    1 interaction

    Caution Advised

    brexpiprazole + elinzanetant

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • escitalopram
  • Rexulti (brexpiprazole)
    +
    escitalopram
    1 interaction

    Caution Advised

    brexpiprazole + escitalopram

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • eslicarbazepine acetate
  • Rexulti (brexpiprazole)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    brexpiprazole + eslicarbazepine acetate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • ethosuximide
  • Rexulti (brexpiprazole)
    +
    ethosuximide
    1 interaction

    Caution Advised

    brexpiprazole + ethosuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • felbamate
  • Rexulti (brexpiprazole)
    +
    felbamate
    1 interaction

    Caution Advised

    brexpiprazole + felbamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • fenfluramine
  • Rexulti (brexpiprazole)
    +
    fenfluramine
    1 interaction

    Caution Advised

    brexpiprazole + fenfluramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • fesoterodine
  • Rexulti (brexpiprazole)
    +
    fesoterodine
    1 interaction

    Caution Advised

    brexpiprazole + fesoterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • flavoxate
  • Rexulti (brexpiprazole)
    +
    flavoxate
    1 interaction

    Caution Advised

    brexpiprazole + flavoxate

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • fluvoxamine
  • Rexulti (brexpiprazole)
    +
    fluvoxamine
    1 interaction

    Caution Advised

    brexpiprazole + fluvoxamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • frovatriptan
  • Rexulti (brexpiprazole)
    +
    frovatriptan
    1 interaction

    Caution Advised

    brexpiprazole + frovatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • galantamine
  • Rexulti (brexpiprazole)
    +
    galantamine
    1 interaction

    Caution Advised

    brexpiprazole + galantamine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • ganaxolone
  • Rexulti (brexpiprazole)
    +
    ganaxolone
    1 interaction

    Caution Advised

    brexpiprazole + ganaxolone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • glofitamab
  • Rexulti (brexpiprazole)
    +
    glofitamab
    1 interaction

    Caution Advised

    brexpiprazole + glofitamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • glycopyrrolate
  • Rexulti (brexpiprazole)
    +
    glycopyrrolate
    1 interaction

    Caution Advised

    brexpiprazole + glycopyrrolate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • glycopyrrolate inhaled
  • Rexulti (brexpiprazole)
    +
    glycopyrrolate inhaled
    1 interaction

    Caution Advised

    brexpiprazole + glycopyrrolate inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • glycopyrronium topical
  • Rexulti (brexpiprazole)
    +
    glycopyrronium topical
    1 interaction

    Caution Advised

    brexpiprazole + glycopyrronium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • homatropine
  • Rexulti (brexpiprazole)
    +
    homatropine
    1 interaction

    Caution Advised

    brexpiprazole + homatropine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • hydroxychloroquine
  • Rexulti (brexpiprazole)
    +
    hydroxychloroquine
    1 interaction

    Caution Advised

    brexpiprazole + hydroxychloroquine

    caution advised: combo may incr. risk of seizures (additive effects)

  • hyoscyamine
  • Rexulti (brexpiprazole)
    +
    hyoscyamine
    1 interaction

    Caution Advised

    brexpiprazole + hyoscyamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ipratropium inhaled
  • Rexulti (brexpiprazole)
    +
    ipratropium inhaled
    1 interaction

    Caution Advised

    brexpiprazole + ipratropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • lacosamide
  • Rexulti (brexpiprazole)
    +
    lacosamide
    1 interaction

    Caution Advised

    brexpiprazole + lacosamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • lamotrigine
  • Rexulti (brexpiprazole)
    +
    lamotrigine
    1 interaction

    Caution Advised

    brexpiprazole + lamotrigine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • levetiracetam
  • Rexulti (brexpiprazole)
    +
    levetiracetam
    1 interaction

    Caution Advised

    brexpiprazole + levetiracetam

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • levocetirizine
  • Rexulti (brexpiprazole)
    +
    levocetirizine
    1 interaction

    Caution Advised

    brexpiprazole + levocetirizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • levomilnacipran
  • Rexulti (brexpiprazole)
    +
    levomilnacipran
    1 interaction

    Caution Advised

    brexpiprazole + levomilnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • linvoseltamab
  • Rexulti (brexpiprazole)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    brexpiprazole + linvoseltamab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • magnesium citrate
  • Rexulti (brexpiprazole)
    +
    magnesium citrate
    1 interaction

    Caution Advised

    brexpiprazole + magnesium citrate

    caution advised, especially if magnesium citrate bowel prep use: combo may incr. risk of seizures (additive effects)

  • meclizine
  • Rexulti (brexpiprazole)
    +
    meclizine
    1 interaction

    Caution Advised

    brexpiprazole + meclizine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • melatonin
  • Rexulti (brexpiprazole)
    +
    melatonin
    1 interaction

    Caution Advised

    brexpiprazole + melatonin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • meprobamate
  • Rexulti (brexpiprazole)
    +
    meprobamate
    1 interaction

    Caution Advised

    brexpiprazole + meprobamate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methazolamide
  • Rexulti (brexpiprazole)
    +
    methazolamide
    1 interaction

    Caution Advised

    brexpiprazole + methazolamide

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • methocarbamol
  • Rexulti (brexpiprazole)
    +
    methocarbamol
    1 interaction

    Caution Advised

    brexpiprazole + methocarbamol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • methscopolamine
  • Rexulti (brexpiprazole)
    +
    methscopolamine
    1 interaction

    Caution Advised

    brexpiprazole + methscopolamine

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • methsuximide
  • Rexulti (brexpiprazole)
    +
    methsuximide
    1 interaction

    Caution Advised

    brexpiprazole + methsuximide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • metyrapone
  • Rexulti (brexpiprazole)
    +
    metyrapone
    1 interaction

    Caution Advised

    brexpiprazole + metyrapone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • metyrosine
  • Rexulti (brexpiprazole)
    +
    metyrosine
    1 interaction

    Caution Advised

    brexpiprazole + metyrosine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms (additive effects)

  • milnacipran
  • Rexulti (brexpiprazole)
    +
    milnacipran
    1 interaction

    Caution Advised

    brexpiprazole + milnacipran

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mosunetuzumab
  • Rexulti (brexpiprazole)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    brexpiprazole + mosunetuzumab

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • mycophenolate mofetil
  • Rexulti (brexpiprazole)
    +
    mycophenolate mofetil
    1 interaction

    Caution Advised

    brexpiprazole + mycophenolate mofetil

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naltrexone
  • Rexulti (brexpiprazole)
    +
    naltrexone
    1 interaction

    Caution Advised

    brexpiprazole + naltrexone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • naratriptan
  • Rexulti (brexpiprazole)
    +
    naratriptan
    1 interaction

    Caution Advised

    brexpiprazole + naratriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • orphenadrine
  • Rexulti (brexpiprazole)
    +
    orphenadrine
    1 interaction

    Caution Advised

    brexpiprazole + orphenadrine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • oxcarbazepine
  • Rexulti (brexpiprazole)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    brexpiprazole + oxcarbazepine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • passion flower
  • Rexulti (brexpiprazole)
    +
    passion flower
    1 interaction

    Caution Advised

    brexpiprazole + passion flower

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • perampanel
  • Rexulti (brexpiprazole)
    +
    perampanel
    1 interaction

    Caution Advised

    brexpiprazole + perampanel

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • pheniramine
  • Rexulti (brexpiprazole)
    +
    pheniramine
    1 interaction

    Caution Advised

    brexpiprazole + pheniramine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • pimozide
  • Rexulti (brexpiprazole)
    +
    pimozide
    1 interaction

    Caution Advised

    brexpiprazole + pimozide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, extrapyramidal symptoms, hyperthermia (additive effects)

  • polyethylene glycol
  • Rexulti (brexpiprazole)
    +
    polyethylene glycol
    1 interaction

    Caution Advised

    brexpiprazole + polyethylene glycol

    caution advised, especially if polyethylene glycol bowel prep use: combo may incr. risk of seizures (additive effects)

  • polyethylene glycol/electrolytes
  • Rexulti (brexpiprazole)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Caution Advised

    brexpiprazole + polyethylene glycol/ electrolytes

    caution advised: combo may incr. risk of seizures (additive effects)

  • pyrilamine
  • Rexulti (brexpiprazole)
    +
    pyrilamine
    1 interaction

    Caution Advised

    brexpiprazole + pyrilamine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • ramelteon
  • Rexulti (brexpiprazole)
    +
    ramelteon
    1 interaction

    Caution Advised

    brexpiprazole + ramelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • revefenacin inhaled
  • Rexulti (brexpiprazole)
    +
    revefenacin inhaled
    1 interaction

    Caution Advised

    brexpiprazole + revefenacin inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • rivastigmine
  • Rexulti (brexpiprazole)
    +
    rivastigmine
    1 interaction

    Caution Advised

    brexpiprazole + rivastigmine

    caution advised: combo may incr. risk of extrapyramidal symptoms (additive effects)

  • rizatriptan
  • Rexulti (brexpiprazole)
    +
    rizatriptan
    1 interaction

    Caution Advised

    brexpiprazole + rizatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • rufinamide
  • Rexulti (brexpiprazole)
    +
    rufinamide
    1 interaction

    Caution Advised

    brexpiprazole + rufinamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • selinexor
  • Rexulti (brexpiprazole)
    +
    selinexor
    1 interaction

    Caution Advised

    brexpiprazole + selinexor

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sertraline
  • Rexulti (brexpiprazole)
    +
    sertraline
    1 interaction

    Caution Advised

    brexpiprazole + sertraline

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • sodium picosulfate
  • Rexulti (brexpiprazole)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    brexpiprazole + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sofpironium topical
  • Rexulti (brexpiprazole)
    +
    sofpironium topical
    1 interaction

    Caution Advised

    brexpiprazole + sofpironium topical

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • solifenacin
  • Rexulti (brexpiprazole)
    +
    solifenacin
    1 interaction

    Caution Advised

    brexpiprazole + solifenacin

    caution advised: combo may incr. risk of hyperthermia, CNS depression, psychomotor impairment (additive effects)

  • stiripentol
  • Rexulti (brexpiprazole)
    +
    stiripentol
    1 interaction

    Caution Advised

    brexpiprazole + stiripentol

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • sulfate bowel prep
  • Rexulti (brexpiprazole)
    +
    sulfate bowel prep
    1 interaction

    Caution Advised

    brexpiprazole + sulfate bowel prep

    caution advised: combo may incr. risk of seizures (additive effects)

  • sumatriptan
  • Rexulti (brexpiprazole)
    +
    sumatriptan
    1 interaction

    Caution Advised

    brexpiprazole + sumatriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tasimelteon
  • Rexulti (brexpiprazole)
    +
    tasimelteon
    1 interaction

    Caution Advised

    brexpiprazole + tasimelteon

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tetrabenazine
  • Rexulti (brexpiprazole)
    +
    tetrabenazine
    1 interaction

    Caution Advised

    brexpiprazole + tetrabenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • thiotepa
  • Rexulti (brexpiprazole)
    +
    thiotepa
    1 interaction

    Caution Advised

    brexpiprazole + thiotepa

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • tiagabine
  • Rexulti (brexpiprazole)
    +
    tiagabine
    1 interaction

    Caution Advised

    brexpiprazole + tiagabine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • tiotropium inhaled
  • Rexulti (brexpiprazole)
    +
    tiotropium inhaled
    1 interaction

    Caution Advised

    brexpiprazole + tiotropium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • tolterodine
  • Rexulti (brexpiprazole)
    +
    tolterodine
    1 interaction

    Caution Advised

    brexpiprazole + tolterodine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • topiramate
  • Rexulti (brexpiprazole)
    +
    topiramate
    1 interaction

    Caution Advised

    brexpiprazole + topiramate

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • treosulfan
  • Rexulti (brexpiprazole)
    +
    treosulfan
    1 interaction

    Caution Advised

    brexpiprazole + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • trihexyphenidyl
  • Rexulti (brexpiprazole)
    +
    trihexyphenidyl
    1 interaction

    Caution Advised

    brexpiprazole + trihexyphenidyl

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • triprolidine
  • Rexulti (brexpiprazole)
    +
    triprolidine
    1 interaction

    Caution Advised

    brexpiprazole + triprolidine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • trospium
  • Rexulti (brexpiprazole)
    +
    trospium
    1 interaction

    Caution Advised

    brexpiprazole + trospium

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia (additive effects)

  • umeclidinium inhaled
  • Rexulti (brexpiprazole)
    +
    umeclidinium inhaled
    1 interaction

    Caution Advised

    brexpiprazole + umeclidinium inhaled

    caution advised: combo may incr. risk of hyperthermia (additive effects)

  • valbenazine
  • Rexulti (brexpiprazole)
    +
    valbenazine
    1 interaction

    Caution Advised

    brexpiprazole + valbenazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valerian
  • Rexulti (brexpiprazole)
    +
    valerian
    1 interaction

    Caution Advised

    brexpiprazole + valerian

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • valproic acid
  • Rexulti (brexpiprazole)
    +
    valproic acid
    1 interaction

    Caution Advised

    brexpiprazole + valproic acid

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • venlafaxine
  • Rexulti (brexpiprazole)
    +
    venlafaxine
    1 interaction

    Caution Advised

    brexpiprazole + venlafaxine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • vigabatrin
  • Rexulti (brexpiprazole)
    +
    vigabatrin
    1 interaction

    Caution Advised

    brexpiprazole + vigabatrin

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

  • vilazodone
  • Rexulti (brexpiprazole)
    +
    vilazodone
    1 interaction

    Caution Advised

    brexpiprazole + vilazodone

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • viloxazine
  • Rexulti (brexpiprazole)
    +
    viloxazine
    1 interaction

    Caution Advised

    brexpiprazole + viloxazine

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zolmitriptan
  • Rexulti (brexpiprazole)
    +
    zolmitriptan
    1 interaction

    Caution Advised

    brexpiprazole + zolmitriptan

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)

  • zonisamide
  • Rexulti (brexpiprazole)
    +
    zonisamide
    1 interaction

    Caution Advised

    brexpiprazole + zonisamide

    caution advised: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia; may alter seizure control (additive effects; antagonistic effects, brexpiprazole may decr. seizure threshold)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@6e2310a9
  • neuroleptic malignant syndrome
  • extrapyramidal symptoms, severe
  • tardive dyskinesia
  • dystonia
  • stroke
  • TIA
  • syncope
  • hypotension, orthostatic
  • seizures
  • hyperglycemia
  • diabetes mellitus
  • dysphagia, severe
  • aspiration
  • hyperthermia
  • leukopenia
  • neutropenia
  • agranulocytosis
  • suicidality
  • depression exacerbation

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@4078b84e
  • weight gain
  • hyperglycemia
  • dyslipidemia
  • akathisia
  • extrapyramidal symptoms
  • somnolence
  • weight loss
  • restlessness
  • tremor
  • nasopharyngitis
  • nausea
  • dizziness
  • insomnia
  • anxiety
  • headache
  • appetite incr.
  • impaired body temperature regulation
  • fatigue
  • dyspepsia
  • diarrhea
  • constipation
  • cortisol decr.
  • CPK incr.
  • sedation
  • compulsive behaviors
  • hyperprolactinemia

Safety/Monitoring .

Monitoring Parameters
fasting glucose, lipid profile at baseline, then periodically; CBC with diff frequently during initial tx if pre-existing or history of leukopenia/neutropenia; weight; BP, HR in patients with orthostatic hypotension risk; symptoms of suicidality, clinical worsening, and/or unusual behavior changes, especially during initial tx or after dose changes

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy, especially in 3rd trimester; no human data available, though risk of neonatal extrapyramidal and withdrawal symptoms based on human data with other antipsychotics; no known risk of fetal harm based on animal data at up to 73x and 146x MRHD

Pregnancy Registry

encourage patients to enroll in National Pregnancy Registry for Atypical Antipsychotics at 1-866-961-2388 or www.womensmentalhealth.org

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@455213a

Metabolism: for brexpiprazole: liver; CYP450: 2D6, 3A4 substrate; Info: CYP2D6 poor metabolizers have 4.8 fold increased active drug exposure

Excretion: for brexpiprazole: feces 46% (14% unchanged), urine 25% (<1% unchanged); Half-life: 91h

Subclass: Antipsychotics, 2nd generation

Mechanism of Action
for brexpiprazole: exact mechanism of action unknown; partially agonizes dopamine D2 and serotonin 5-HT1A receptors, antagonizes serotonin 5-HT2A receptors

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Otsuka America Pharmaceuticals, Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@6421c7fb

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral tablet:

  • 0.25 mg (30 ea): $1,281.00
  • 0.5 mg (30 ea): $1,281.00
  • 1 mg (30 ea): $1,281.00
  • 2 mg (30 ea): $1,281.00
  • 3 mg (30 ea): $1,281.00
  • 4 mg (30 ea): $1,281.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information